Pharma in China, untapped markets and drug development

GOLD Podcast | Season 2: Episode 07

In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuticals.

Spotify | Apple | Acast | Amazon Music

Download MP3 (mp3, 32:07 mins)

Click here to subscribe to the weekly newsletter for more insights from GOLD.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Pharma in… China
• A big boom in biotech
• A heyday for mRNA
• The vast galaxy of neurology